Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Traditional signs and symptoms commonly attributed to hypogonadism do not correlate with testosterone levels: the Cooper Center Longitudinal Study Experience.

DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, Vega GL, Barlow CE, Willis BL, Gibbons LW, Gruntmanis U.

J Investig Med. 2020 Feb;68(2):378-382. doi: 10.1136/jim-2019-001083. Epub 2019 Sep 20.

PMID:
31540967
2.

The association of cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal Study.

DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, Willis BL, Vega GL, Barlow CE, Farrell SW, Gibbons LW, Yildiz BO, Gruntmanis U.

Maturitas. 2018 Dec;118:1-6. doi: 10.1016/j.maturitas.2018.09.004. Epub 2018 Sep 29.

PMID:
30415749
3.

Could Grape Seed Extract Be an Alternative Treatment in the Management of Hot Flashes?-Reply.

Gupta A, Sadeghi N, Gruntmanis U.

JAMA Oncol. 2018 Aug 1;4(8):1139. doi: 10.1001/jamaoncol.2018.1108. No abstract available.

PMID:
29931090
4.

Unnecessary Thyroid Ultrasonography in the Evaluation of Laboratory Thyroid Abnormalities.

Gupta A, Arora N, Gruntmanis U.

JAMA Intern Med. 2017 Dec 1;177(12):1851-1852. doi: 10.1001/jamainternmed.2017.5521. No abstract available.

PMID:
29084333
5.

Corrigendum to "Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy".

Neubecker K, Adams-Huet B, Farukhi IM, Castanon R, Gruntmanis U.

J Osteoporos. 2017;2017:4982312. doi: 10.1155/2017/4982312. Epub 2017 Jul 12.

6.

Value in the Step 2 Clinical Skills Examination.

Gupta A, Gruntmanis U.

JAMA Intern Med. 2017 Feb 1;177(2):292. doi: 10.1001/jamainternmed.2016.8227. No abstract available.

PMID:
28166338
7.

The Relationship Between Cardiorespiratory Fitness and Bone Mineral Density in Men: A Cross-sectional Study.

Wainstein HM, Feldman M, Shen CL, Leonard D, Willis BL, Finley CE, Gruntmanis U, DeFina LF.

Mayo Clin Proc. 2016 Jun;91(6):726-34. doi: 10.1016/j.mayocp.2016.02.025. Epub 2016 Apr 14.

PMID:
27087452
8.

Visual Vignette.

Flores JF, DeGueme A, Hussain I, Cavuoti D, Gruntmanis U, Gunasekaran U.

Endocr Pract. 2015 Nov;21(11):1309. doi: 10.4158/EP15923.VV. Epub 2015 Aug 26. No abstract available.

PMID:
26307901
9.

Systemic Mastocytosis With Decreased Bone Density and Fractures.

Zechner C, Gruntmanis U.

Mayo Clin Proc. 2015 Jun;90(6):843-4. doi: 10.1016/j.mayocp.2014.10.014. No abstract available.

10.

Fracture incidence in a large cohort of men age 30 years and older with osteoporosis.

Manthripragada AD, O'Malley CD, Gruntmanis U, Hall JW, Wagman RB, Miller PD.

Osteoporos Int. 2015 May;26(5):1619-27. doi: 10.1007/s00198-015-3035-z. Epub 2015 Jan 24.

PMID:
25616508
11.

A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.

Langdahl BL, Teglbjærg CS, Ho PR, Chapurlat R, Czerwinski E, Kendler DL, Reginster JY, Kivitz A, Lewiecki EM, Miller PD, Bolognese MA, McClung MR, Bone HG, Ljunggren Ö, Abrahamsen B, Gruntmanis U, Yang YC, Wagman RB, Mirza F, Siddhanti S, Orwoll E.

J Clin Endocrinol Metab. 2015 Apr;100(4):1335-42. doi: 10.1210/jc.2014-4079. Epub 2015 Jan 21.

PMID:
25607608
12.

A cross-sectional survey of urinary iodine status in Latvia.

Konrade I, Neimane L, Makrecka M, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pīrāgs V, Dambrova M.

Medicina (Kaunas). 2014;50(2):124-9. doi: 10.1016/j.medici.2014.06.003. Epub 2014 Jun 27.

13.

Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.

Ruza I, Mirfakhraee S, Orwoll E, Gruntmanis U.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):182-98. doi: 10.1177/1759720X13485829.

14.

Risk factors for diminished bone mineral density among male hemodialysis patients--a cross-sectional study.

Mirfakhraee S, Sakhaee K, Zerwekh J, Adams-Huet B, Gruntmanis U.

Arch Osteoporos. 2012;7:283-90.

PMID:
23152064
15.

Seasonal iodine deficiency in Latvian school children.

Konrade I, Dambrova M, Makrecka M, Neimane L, Strele I, Liepinsh E, Lejnieks A, Vevere P, Gruntmanis U, Pirags V.

Thyroid. 2012 Oct;22(10):1088-9. doi: 10.1089/thy.2011.0506. Epub 2012 Sep 4. No abstract available.

PMID:
22947352
16.

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.

Orwoll E, Teglbjærg CS, Langdahl BL, Chapurlat R, Czerwinski E, Kendler DL, Reginster JY, Kivitz A, Lewiecki EM, Miller PD, Bolognese MA, McClung MR, Bone HG, Ljunggren Ö, Abrahamsen B, Gruntmanis U, Yang YC, Wagman RB, Siddhanti S, Grauer A, Hall JW, Boonen S.

J Clin Endocrinol Metab. 2012 Sep;97(9):3161-9. doi: 10.1210/jc.2012-1569. Epub 2012 Jun 21.

PMID:
22723310
17.

The role of 5α-reductase inhibition in men receiving testosterone replacement therapy.

Gruntmanis U.

JAMA. 2012 Mar 7;307(9):968-70. doi: 10.1001/jama.2012.259. No abstract available.

PMID:
22396520
18.

Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy.

Neubecker K, Adams-Huet B, Farukhi IM, Delapena RC, Gruntmanis U.

J Osteoporos. 2011;2011:924595. doi: 10.4061/2011/924595. Epub 2011 Jul 28. Erratum in: J Osteoporos. 2017;2017:4982312.

19.

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial.

Gruntmanis U, Fordan S, Ghayee HK, Abdullah SM, See R, Ayers CR, McGuire DK.

Calcif Tissue Int. 2010 May;86(5):343-9. doi: 10.1007/s00223-010-9352-5. Epub 2010 Mar 31.

PMID:
20354684
20.

Efficacy and safety of monthly ibandronate in men with low bone density.

Orwoll ES, Binkley NC, Lewiecki EM, Gruntmanis U, Fries MA, Dasic G.

Bone. 2010 Apr;46(4):970-6. doi: 10.1016/j.bone.2009.12.034. Epub 2010 Jan 6.

PMID:
20060082
21.

Management of osteoporosis in the aging male: focus on zoledronic acid.

Piper PK Jr, Gruntmanis U.

Clin Interv Aging. 2009;4:289-303. Epub 2009 Jun 29. Review.

22.

Comparison of testosterone, alendronate, and a combination of both therapies in men with low bone mineral density.

Welch BJ, Denke MA, Kermani A, Adams-Huet B, Gazmen NM, Gruntmanis U.

J Investig Med. 2007 May;55(4):168-73. doi: 10.2310/6650.2007.06047.

PMID:
17651670
23.

Male osteoporosis: deadly, but ignored.

Gruntmanis U.

Am J Med Sci. 2007 Feb;333(2):85-92. Review.

PMID:
17301586
24.

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA.

Am J Cardiol. 2007 Feb 15;99(4):513-8. Epub 2006 Dec 28.

PMID:
17293196
25.

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS.

Gut. 2004 Aug;53(8):1129-36.

26.

Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds.

Eng ET, Ye J, Williams D, Phung S, Moore RE, Young MK, Gruntmanis U, Braunstein G, Chen S.

Cancer Res. 2003 Dec 1;63(23):8516-22.

27.

Treatment of gynecomastia.

Gruntmanis U, Braunstein GD.

Curr Opin Investig Drugs. 2001 May;2(5):643-9. Review.

PMID:
11569940

Supplemental Content

Loading ...
Support Center